Correlation Between Enhancement Patterns on Transabdominal Ultrasound and Survival for Pancreatic Ductal Adenocarcinoma

References

• Miller KD , Siegel RL , Lin CC , et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin . 2016;66(4):271–289. doi:10.3322/caac.21349 27253694
   PubMed Web of Science ®Google Scholar
• Conlon KC , Klimstra DS , Brennan MF . Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg . 1996;223(3):273–279. doi:10.1097/00000658-199603000-00007 8604907
   PubMed Web of Science ®Google Scholar
• Lin LZ , Li F , Liu Y , Xing LX , Du LF . Contrast-enhanced ultrasound for differential diagnosis of pancreatic mass lesions: a meta-analysis. Med Ultrason . 2016;18(2):163–169. doi:10.11152/mu.2013.2066.182.ceu 27239649
   PubMed Web of Science ®Google Scholar
• Sidhu PS , Cantisani V , Dietrich CF , et al. The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications: update 2017 (short version). Ultraschall Med . 2018;39(02):154–180. doi:10.1055/s-0044-101254 29510440
   PubMed Web of Science ®Google Scholar
• Zhu L , Shi X , Xue H , et al. CT imaging biomarkers predict clinical outcomes after pancreatic cancer surgery. Medicine (Baltimore) . 2016;95(5):e2664. doi:10.1097/MD.0000000000002664 26844495
   PubMed Web of Science ®Google Scholar
• Gong TT , Hu DM , Zhu Q . Contrast-enhanced EUS for differential diagnosis of pancreatic mass lesions: a meta-analysis. Gastrointest Endosc . 2012;76(2):301–309. doi:10.1016/j.gie.2012.02.051 22703697
   PubMed Web of Science ®Google Scholar
• D’Onofrio M , Biagioli E , Gerardi C , et al. Diagnostic performance of contrast-enhanced ultrasound (CEUS) and contrast-enhanced endoscopic ultrasound (ECEUS) for the differentiation of pancreatic lesions: a systematic review and meta-analysis. Ultraschall Med . 2014;35(06):515–521. doi:10.1055/s-0034-1385068 25226455
   PubMed Web of Science ®Google Scholar
• Iglesias-Garcia J , Lindkvist B , Larino-Noia J , Abdulkader-Nallib I , Dominguez-Munoz JE . Differential diagnosis of solid pancreatic masses: contrast-enhanced harmonic (CEH-EUS), quantitative-elastography (QE-EUS), or both? Uni Eur Gastroenterol J . 2017;5(2):236–246. doi:10.1177/2050640616640635
   PubMed Web of Science ®Google Scholar
• Leem G , Chung MJ , Park JY , et al. Clinical value of contrast-enhanced harmonic endoscopic ultrasonography in the differential diagnosis of pancreatic and gallbladder masses. Clin Endosc . 2018;51(1):80–88. doi:10.5946/ce.2017.044 28928356
   PubMed Web of Science ®Google Scholar
• Rickes S , Monkemuller K , Malfertheiner P . Contrast-enhanced ultrasound in the diagnosis of pancreatic tumors. JOP . 2006;7:584–592.17095837
   PubMedGoogle Scholar
• Beyer-Enke SA , Hocke M , Ignee A , Braden B , Dietrich CF . Contrast enhanced transabdominal ultrasound in the characterisation of pancreatic lesions with cystic appearance. JOP . 2010;11:427–433.20818109
   PubMedGoogle Scholar
• D’Onofrio M , Canestrini S , Crosara S , De Robertis R , Pozzi Mucelli R . Contrast enhanced ultrasound with quantitative perfusion analysis for objective characterization of pancreatic ductal adenocarcinoma: a Feasibility Study. World J Radiol . 2014;6(3):31–35. doi:10.4329/wjr.v6.i3.31 24765238
   PubMedGoogle Scholar
• Kitano M , Kamata K , Imai H , et al. Contrast-enhanced harmonic endoscopic ultrasonography for pancreatobiliary diseases. Dig Endosc . 2015;27(Suppl 1):60–67. doi:10.1111/den.12454 25639788
   PubMed Web of Science ®Google Scholar
• Kersting S , Konopke R , Kersting F , et al. Quantitative perfusion analysis of transabdominal contrast-enhanced ultrasonography of pancreatic masses and carcinomas. Gastroenterology . 2009;137(6):1903–1911. doi:10.1053/j.gastro.2009.08.049 19715694
   PubMed Web of Science ®Google Scholar
• D’Onofrio M , Barbi E , Dietrich CF , et al. Pancreatic multicenter ultrasound study (PAMUS). Eur J Radiol . 2012;81(4):630–638. doi:10.1016/j.ejrad.2011.01.053 21466935
   PubMed Web of Science ®Google Scholar
• Yoon SH , Lee JM , Cho JY , et al. Small (</= 20 mm) pancreatic adenocarcinomas: analysis of enhancement patterns and secondary signs with multiphasic multidetector CT. Radiology . 2011;259:442–452. doi:10.1148/radiol.11101133 21406627
   PubMed Web of Science ®Google Scholar
• Lee S , Kim SH , Park HK , Jang KT , Hwang JA , Kim S . Pancreatic ductal adenocarcinoma: rim enhancement at MR imaging predicts prognosis after curative resection. Radiology . 2018;288(2):456–466. doi:10.1148/radiol.2018172331 29664340
   PubMed Web of Science ®Google Scholar
• Akasu G , Kawahara R , Yasumoto M , et al. Clinicopathological analysis of contrast-enhanced ultrasonography using perflubutane in pancreatic adenocarcinoma. Kurume Med J . 2012;59(3.4):45–52. doi:10.2739/kurumemedj.59.45 23823014
   PubMedGoogle Scholar
• Catalano V , Turdo A , Di Franco S , Dieli F , Todaro M , Stassi G . Tumor and its microenvironment: a synergistic interplay. Semin Cancer Biol . 2013;23(6):522–532. doi:10.1016/j.semcancer.2013.08.007 24012661
   PubMed Web of Science ®Google Scholar
• Hata H , Mori H , Matsumoto S , et al. Fibrous stroma and vascularity of pancreatic carcinoma: correlation with enhancement patterns on CT. Abdom Imaging . 2010;35(2):172–180. doi:10.1007/s00261-008-9460-0 18815826
   PubMedGoogle Scholar
• D’Onofrio M , Malago R , Zamboni G , et al. Contrast-enhanced ultrasonography better identifies pancreatic tumor vascularization than helical CT. Pancreatology . 2005;5(4–5):398–402. doi:10.1159/000086540 15985763
   PubMed Web of Science ®Google Scholar
• Nishida M , Koito K , Hirokawa N , Hori M , Satoh T , Hareyama M . Does contrast-enhanced ultrasound reveal tumor angiogenesis in pancreatic ductal carcinoma? A prospective study. Ultrasound Med Biol . 2009;35(2):175–185. doi:10.1016/j.ultrasmedbio.2008.08.008 18845377
   PubMed Web of Science ®Google Scholar
• D’Onofrio M , Zamboni GA , Malago R , et al. Resectable pancreatic adenocarcinoma: is the enhancement pattern at contrast-enhanced ultrasonography a pre-operative prognostic factor? Ultrasound Med Biol . 2009;35(12):1929–1937. doi:10.1016/j.ultrasmedbio.2009.06.1100 19828234
   PubMed Web of Science ®Google Scholar
• Erkan M , Kleeff J , Gorbachevski A , et al. Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity. Gastroenterology . 2007;132(4):1447–1464. doi:10.1053/j.gastro.2007.01.031 17408641
   PubMed Web of Science ®Google Scholar
• Erkan M . The role of pancreatic stellate cells in pancreatic cancer. Pancreatology . 2013;13(2):106–109. doi:10.1016/j.pan.2013.01.008 23561966
   PubMed Web of Science ®Google Scholar
• Fujita H , Ohuchida K , Mizumoto K , et al. alpha-smooth muscle actin expressing stroma promotes an aggressive tumor biology in pancreatic ductal adenocarcinoma. Pancreas . 2010;39(8):1254–1262. doi:10.1097/MPA.0b013e3181dbf647 20467342
   PubMed Web of Science ®Google Scholar
• Kuwahara K , Sasaki T , Kuwada Y , Murakami M , Yamasaki S , Chayama K . Expressions of angiogenic factors in pancreatic ductal carcinoma: a correlative study with clinicopathologic parameters and patient survival. Pancreas . 2003;26(4):344–349. doi:10.1097/00006676-200305000-00006 12717266
   PubMed Web of Science ®Google Scholar